Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by Lifestar Pharma LLC, priced at $0.2214 per EA under NDC 70756081430. Its NADAC has been published 311 times since Sep 9, 2020.
FDA first approved this application on Sep 17, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB
Olmesartan Medoxomil and HydrochlorothiazideStrength
25; 40 mg/1; mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756081430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA208847FDA Approved
9/17/2019
TE Code
AB
On Market Since
10/1/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 311 times since Sep 9, 2020, and over the history we have for it it has declined 68.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2214 per EA |
|---|---|
| All-time high | $0.8042 (Oct 14, 2020) |
| All-time low | $0.1789 (Nov 20, 2024) |
| 52-week high | $0.2343 |
| 52-week low | $0.2023 |
| Median price | $0.2694 |
| Average price | $0.2848 |
| Largest weekly change | -46.8% (Nov 18, 2020) |
| Weeks tracked | 311 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, manufactured by Lifestar Pharma LLC, is $0.2214 per EA (NDC 70756081430), effective Aug 19, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has declined 68.3%. It has been tracked across 311 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
Since Sep 9, 2020, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has ranged from a low of $0.1789 (Nov 20, 2024) to a high of $0.8042 (Oct 14, 2020), with a median of $0.2694 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB (NDC 70756081430) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.